Contents

Current Pharmaceutical Design, Volume 10 - Number 1

Preface [Hot topic: Angiogenesis Agents (Executive Editor: Cezary Marcinkiewicz)]

, 10(1): ii

Cezary Marcinkiewicz


DOI: 10.2174/13816128104010100ii




Angiogenesis Inhibitors: Current & Future Directions

, 10(1): 1 - 9

Shaker A. Mousa and Ahmed S. Mousa


DOI: 10.2174/1381612043453531




Angiogenesis: A Target for Cancer Therapy

, 10(1): 11 - 26

Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello


DOI: 10.2174/1381612043453595




Antiangiogenic Therapy

, 10(1): 27 - 37

Daniel Albo, Thomas N. Wang and George P. Tuszynski


DOI: 10.2174/1381612043453522




The Urokinase Plasminogen Activator System: Role in Malignancy

, 10(1): 39 - 49

Michael J. Duffy


DOI: 10.2174/1381612043453559




Resistance to Anti-VEGF Agents

, 10(1): 51 - 64

Ton N. C. and Jayson G. C.


DOI: 10.2174/1381612043453603




Molecular Targeting of Lymphatics for Therapy

, 10(1): 65 - 74

S. A. Stacker, R. A. Hughes and M. G. Achen


DOI: 10.2174/1381612043453513




Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications

, 10(1): 75 - 80

Jorg Wilting and Lothar Schweigerer


DOI: 10.2174/1381612043453577




Author Index to Volume 9

, 10(1): 81 - 87

Bentham Science Publishers


DOI: 10.2174/1381612043453540




Subject Index to Volume 9

, 10(1): 89 - 108

Bentham Science Publishers


DOI: 10.2174/1381612043453568




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science